Michael LaBarre
Chief Tech/Sci/R&D Officer bij HALOZYME THERAPEUTICS, INC.
Vermogen: 7 M $ op 29-02-2024
Profiel
Michael J. LaBarre is Chief Technical Officer & Senior Vice President bij Halozyme Therapeutics, Inc. In zijn vorige carrière was Dr. LaBarre Director-Analytical & Protein Biochemistry bij Biogen, Inc. en Director-Analytical & Formulation Sciences bij IDEC Pharmaceuticals Corp. (een dochteronderneming van Biogen, Inc.) en Vice President-Product Development bij Paramount BioSciences LLC. Dr. LaBarre promoveerde aan de Universiteit van Arizona en promoveerde aan de Stony Brook Universiteit.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
26-03-2024 | 168 176 ( 0.13% ) | 7 M $ | 29-02-2024 |
Actieve functies van Michael LaBarre
Bedrijven | Functie | Begin |
---|---|---|
HALOZYME THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01-01-2020 |
Eerdere bekende functies van Michael LaBarre
Bedrijven | Functie | Einde |
---|---|---|
BIOGEN INC. | Corporate Officer/Principal | 01-04-2006 |
IDEC Pharmaceuticals Corp.
IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | Corporate Officer/Principal | 01-12-2003 |
Paramount BioSciences LLC
Paramount BioSciences LLC Investment ManagersFinance Paramount BioSciences LLC (Paramount) is a venture capital firm founded in 1991. The firm is headquartered in New york. | Corporate Officer/Principal | - |
Opleiding van Michael LaBarre
Stony Brook University | Undergraduate Degree |
University of Arizona | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
BIOGEN INC. | Health Technology |
HALOZYME THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
IDEC Pharmaceuticals Corp.
IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | Health Technology |
Paramount BioSciences LLC
Paramount BioSciences LLC Investment ManagersFinance Paramount BioSciences LLC (Paramount) is a venture capital firm founded in 1991. The firm is headquartered in New york. | Finance |